A trial to assess plerixafor in combination with granulocyte colony stimulating factors, versus granulocyte colony stimulating factors alone, for stem cell mobilisation in patients with multiple myeloma and non-Hodgkin's lymphoma.
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2014
At a glance
- Drugs Plerixafor (Primary) ; Granulocyte colony-stimulating factors
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 09 Oct 2014 New trial record